
HCA Healthcare, Inc.
HCANYSECIK 860730HealthcareFiscal year ends Dec 31
Reports and events: 370 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-05-0416:35 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-150111 |
| 2021-04-3016:38 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-145306 |
| 2021-04-2208:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-125676 |
| 2021-04-0917:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-111694 |
| 2021-03-1916:54 ET | DEF 14A | Proxy statementPeriod 2021-04-28 | 0001193125-21-087653 |
| 2021-02-1916:28 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001193125-21-048994 |
| 2021-02-0208:09 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-025346 |
| 2020-10-2916:22 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001193125-20-281070 |
| 2020-10-2608:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-276104 |
| 2020-10-0817:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-266399 |
| 2020-07-3018:51 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001193125-20-204191 |
| 2020-07-2208:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-196820 |
| 2020-05-0617:04 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001193125-20-135021 |
| 2020-05-0617:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-20-135015 |
| 2020-04-2108:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-112965 |
| 2020-04-0216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-096038 |
| 2020-03-2017:18 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-080819 |
| 2020-03-2016:18 ET | DEF 14A | Proxy statementPeriod 2020-05-01 | 0001193125-20-080679 |
| 2020-02-2617:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-050213 |
| 2020-02-2016:20 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001193125-20-043524 |
| 2020-02-1217:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-033383 |
| 2020-02-1107:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-030658 |
| 2020-01-2808:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-016154 |
| 2019-11-2116:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-297641 |
| 2019-11-0116:33 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001193125-19-281996 |
| 2019-10-2908:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-277113 |
| 2019-10-1016:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-265871 |
| 2019-08-0216:46 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001193125-19-212115 |
| 2019-07-3009:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-206299 |
| 2019-07-2216:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-199011 |
| 2019-06-1216:49 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-171339 |
| 2019-06-0716:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-168266 |
| 2019-05-0317:54 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001193125-19-135292 |
| 2019-05-0216:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-19-135052 |
| 2019-04-3008:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-127530 |
| 2019-04-0217:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-095729 |
| 2019-03-1516:31 ET | DEF 14A | Proxy statementPeriod 2019-04-26 | 0001193125-19-076774 |
| 2019-02-2517:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-050027 |
| 2019-02-2116:37 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001193125-19-047078 |
| 2019-01-3017:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-022657 |
| 2019-01-2909:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-019842 |
| 2019-01-2216:40 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-014056 |
| 2019-01-1708:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-010996 |
| 2018-12-2116:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-18-356414 |
| 2018-11-0616:48 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001193125-18-319640 |
| 2018-10-3008:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-311386 |
| 2018-09-1217:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-18-271892 |
| 2018-08-2316:44 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-18-256366 |
| 2018-08-1317:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-247443 |
| 2018-08-0316:44 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001193125-18-238342 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.